Assignee
ASANA BIOSCIENCES LLC
US35 patents
Top patents by PatentIndex Score
US9944637B2Apr 17, 2018
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC5 citations82
US9908879B2Mar 6, 2018
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC5 citations82
US9382277B2Jul 5, 2016
Pyrimido-pyridazinone compounds and methods of use thereof
ASANA BIOSCIENCES LLC8 citations82
US10174039B2Jan 8, 2019
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC4 citations81
US9499495B2Nov 22, 2016
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
ASANA BIOSCIENCES LLC4 citations80
US10316080B2Jun 11, 2019
Protein-polymer-drug conjugates
ASANA BIOSCIENCES LLC4 citations72
US11103491B2Aug 31, 2021
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC2 citations71
US10751332B2Aug 25, 2020
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC2 citations71
US10647720B2May 12, 2020
Pyrimido-pyridazinone compounds and methods of use thereof
ASANA BIOSCIENCES LLC1 citations71
US10590127B2Mar 17, 2020
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC1 citations71
US10544145B2Jan 28, 2020
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC1 citations71
US10316039B2Jun 11, 2019
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC2 citations71
US10188654B2Jan 29, 2019
Uses of pyrimido-pyridazinones to treat cancer
ASANA BIOSCIENCES LLC3 citations71
US11339169B2May 24, 2022
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC2 citations70
US10611768B2Apr 7, 2020
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC2 citations70
US10471051B2Nov 12, 2019
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC3 citations70
US10183944B2Jan 22, 2019
Pyrimido-pyridazinone compounds and methods of use thereof
ASANA BIOSCIENCES LLC1 citations70
US9896445B2Feb 20, 2018
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC3 citations70
US11685736B2Jun 27, 2023
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC0 citations61
US11434278B2Sep 6, 2022
Protein-polymer-drug conjugates
ASANA BIOSCIENCES LLC1 citations61
US9044482B2Jun 2, 2015
Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
ASANA BIOSCIENCES LLC2 citations61
US12077543B2Sep 3, 2024
P2X3 and/or P2X2/3 compounds and methods
ASANA BIOSCIENCES LLC0 citations60
US11925629B2Mar 12, 2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC0 citations60
US10912779B2Feb 9, 2021
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
ASANA BIOSCIENCES LLC0 citations59
US9375423B2Jun 28, 2016
Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
ASANA BIOSCIENCES LLC1 citations51
US9533981B2Jan 3, 2017
Pyridine derivatives
ASANA BIOSCIENCES LLC0 citations50
US9180115B2Nov 10, 2015
Cyclohexylamines
ASANA BIOSCIENCES LLC0 citations50
US9371316B2Jun 21, 2016
Pyridine derivatives
ASANA BIOSCIENCES LLC0 citations49
US9266873B2Feb 23, 2016
Pyridine derivatives
ASANA BIOSCIENCES LLC0 citations49
US9757382B2Sep 12, 2017
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
ASANA BIOSCIENCES LLC0 citations48
US9199975B2Dec 1, 2015
Biaryl imidazole derivatives for regulating CYP17
ASANA BIOSCIENCES LLC0 citations48
US9115092B2Aug 25, 2015
Substituted quinazoline and pyrido-pyrimidine derivatives
ASANA BIOSCIENCES LLC0 citations48
US10226468B2Mar 12, 2019
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
ASANA BIOSCIENCES LLC0 citations47
US9145411B2Sep 29, 2015
Substituted amino-pyrimidine derivatives
ASANA BIOSCIENCES LLC0 citations35
US10695296B2Jun 30, 2020
Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient
ASANA BIOSCIENCES LLC0 citations32